NextGen Healthcare Inc.

23.94
0.03 (0.13%)
At close: Nov 08, 2023, 9:00 PM

NextGen Healthcare Statistics

Share Statistics

NextGen Healthcare has 67.1M shares outstanding. The number of shares has increased by 0% in one year.

Shares Outstanding 67.1M
Shares Change (YoY) 0%
Shares Change (QoQ) 0%
Owned by Institutions (%) n/a
Shares Floating 54.69M
Failed to Deliver (FTD) Shares 37
FTD / Avg. Volume < 0.01%

Short Selling Information

The latest short interest is 4.99M, so 7.44% of the outstanding shares have been sold short.

Short Interest 4.99M
Short % of Shares Out 7.44%
Short % of Float 11.09%
Short Ratio (days to cover) 6.58

Valuation Ratios

The PE ratio is -435.25 and the forward PE ratio is null. NextGen Healthcare's PEG ratio is 1.45.

PE Ratio -435.25
Forward PE n/a
PS Ratio 1.77
Forward PS null
PB Ratio 2.88
P/FCF Ratio 180.61
PEG Ratio 1.45
Financial Ratio History

Enterprise Valuation

NextGen Healthcare has an Enterprise Value (EV) of 1.33B.

EV / Sales 2.04
EV / EBITDA 27.71
EV / EBIT 30.49
EV / FCF 208.13

Financial Position

The company has a current ratio of 2.03, with a Debt / Equity ratio of 0.69.

Current Ratio 2.03
Quick Ratio 1.99
Debt / Equity 0.69
Debt / EBITDA 5.72
Debt / FCF 42.96
Interest Coverage 2.58

Financial Efficiency

Return on Equity is -0.66% and Return on Invested Capital is -1.48%.

Return on Equity -0.66%
Return on Assets -0.3%
Return on Invested Capital -1.48%
Revenue Per Employee $234.7K
Profits Per Employee $-953.65
Employee Count 2,783
Asset Turnover 0.73
Inventory Turnover 47.05

Taxes

Income Tax 6.96M
Effective Tax Rate 161.66%

Stock Price Statistics

The stock price has increased by 0% in the last 52 weeks. The beta is 0.77, so NextGen Healthcare's price volatility has been higher than the market average.

Beta 0.77
52-Week Price Change 0%
50-Day Moving Average 23.78
200-Day Moving Average 18.75
Relative Strength Index (RSI) 82.49
Average Volume (20 Days) 1.26M

Income Statement

In the last 12 months, NextGen Healthcare had revenue of 653.17M and earned -2.65M in profits. Earnings per share was -0.04.

Revenue 653.17M
Gross Profit 311.16M
Operating Income 16.24M
Net Income -2.65M
EBITDA 48.04M
EBIT 10.6M
Earnings Per Share (EPS) -0.04
Full Income Statement

Balance Sheet

The company has 98.72M in cash and 274.76M in debt, giving a net cash position of -176.04M.

Cash & Cash Equivalents 98.72M
Total Debt 274.76M
Net Cash -176.04M
Retained Earnings 127.6M
Total Assets 857.75M
Working Capital 218.92M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 43.66M and capital expenditures -37.26M, giving a free cash flow of 6.4M.

Operating Cash Flow 43.66M
Capital Expenditures -37.26M
Free Cash Flow 6.4M
FCF Per Share 0.1
Full Cash Flow Statement

Margins

Gross margin is 47.64%, with operating and profit margins of 2.49% and -0.41%.

Gross Margin 47.64%
Operating Margin 2.49%
Pretax Margin 0.66%
Profit Margin -0.41%
EBITDA Margin 7.36%
EBIT Margin 2.49%
FCF Margin 0.98%

Dividends & Yields

NXGN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -0.23%
FCF Yield 0.55%
Dividend Details

Analyst Forecast

Currently there are no analyst rating for NXGN.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Stock Splits

The last stock split was on Oct 27, 2011. It was a forward split with a ratio of 2:1.

Last Split Date Oct 27, 2011
Split Type forward
Split Ratio 2:1

Scores

Altman Z-Score 3.61
Piotroski F-Score 2